Locations:
Search IconSearch
March 11, 2022/Cancer/Surgical Oncology

Hybrid Resection of a Fast-Growing Dumbbell Schwannoma: A Case Study

Two-day procedure prevents neurologic compromise for octogenarian

21-CNR-2573159-CQD-Hero-650×450

An 82-year-old woman presented to Cleveland Clinic with right shoulder pain. An MRI of the spine revealed an incidental left paravertebral mass measuring 4.2 cm in maximal direction. There was extension into the T3 intervertebral foramen with remodeling of the adjacent vertebrae.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Because of the relative lack of symptoms on the left and the patient’s concern about having a major surgery at her age, she consulted with the spine team and decided on observation,” says Daniel Raymond, MD, a thoracic surgeon in the Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic.

A mass can be seen pushing the patient’s spinal cord to the right. The tumor extends through the neuroforamen from the outside and into the spinal canal.

Schwannoma surveillance

During the surveillance period, the patient began to develop pain over her left scapula. She underwent physical therapy, but the pain continued intermittently. Seventeen months after her initial MRI, repeat imaging showed significant extension of the schwannoma into the spinal canal, with compression of the thecal sac and contact with the spinal cord.

“Typically, you wouldn’t expect to see a dramatic change in a schwannoma in only a year or so,” says Dr. Raymond. “In this case, the tumor was pushing on the patient’s spine, causing symptoms and growing relatively quickly.” He and Richard Schlenk, MD, a neurosurgeon and Neurosurgery Residency Training Program Director at Cleveland Clinic, decided that a hybrid resection of the dumbbell-shaped schwannoma was the best course of action.

Surgical solution

Dr. Schlenk performed a T2-3 laminectomy using a standard posterior approach to the spinal component of the paravertebral mass. The following day, Dr. Raymond performed robotic thoracic surgery on the remaining intrathoracic component, encircling and removing the mass located on top of the aorta.

Advertisement

The surgeons opted for a two-day procedure due to the patient’s age and her concerns about the recovery process.

“The stress on the system can be a lot for an octogenarian, so we do the spine surgery first and allow the patient to recover overnight,” explains Dr. Raymond. “This approach gives us an opportunity to medically optimize our patients before putting them through a second significant operation.”

The patient in this case had an uncomplicated postoperative course and was discharged home on day four. Pathology results confirmed a grade 1 spinal schwannoma. Her long-term prognosis is excellent.

Team approach

Dr. Raymond credits the success of the surgery to collaboration among the multidisciplinary team. “We have a great system. It’s not about the individual surgeon: It’s the team and culture,” he says.

Working in tandem, clinicians from thoracic surgery and neurosurgery charted a course to treat the patient based on her physiological status, not her chronological age.

“So often, we see people in our clinic who have been told they are too old for surgery,” says Dr. Raymond. “A person like this patient is clearly a candidate for surgery. We gave her an excellent operation and prevented her from serious neurologic compromise. She did great.”

Advertisement

Related Articles

Male patient with doctor
June 17, 2026/Cancer/Patient Support

Overcoming Taboos: Helping Men with Cancer Restore Sexual Health

Creating a safe space for patients

Masked patient with physician
June 15, 2026/Cancer/Patient Support

Managing Infection Risk in the Era of Cell Therapy

Long-term immune effects reshape preventative strategies and timelines

Immune checkpoint inhibitor illustration
June 12, 2026/Cancer/News & Insight

Immunotherapy Appears to Reduce the Risk of Secondary Primary Cancers

Large-scale database also reveals potential for immunotherapy to protect against cancer

T53 mutation illustration
June 10, 2026/Cancer/News & Insight

TP53 Mutation Acquisition Timing Influences Prognosis in Myeloproliferative Neoplasms

Findings may help guide discussions around prognosis and allogeneic stem cell transplantation

Woman consoling another
June 5, 2026/Cancer/Blood Cancers

Equal Access to Modern Therapy May Help Eliminate Survival Differences in Multiple Myeloma

Research underscores the importance of access to timely diagnosis and treatment in this patient population.

Multiple myeloma cells
June 4, 2026/Cancer/Blood Cancers

Machine Learning Model Outperforms Standard Risk Tools for Multiple Myeloma

A Cleveland Clinic model combining clinical staging, genomics and AI predicts survival with 18% greater accuracy — and could help match patients to more effective treatments.

Dr. Kamath & colleagues in the lab
June 2, 2026/Cancer/News & Insight

Tissue Tumor Mutation Burden Outperforms Blood-Based Testing for Predicting Immunotherapy Response

Study serves as ‘cautionary tale’ for physicians tempted to rely on liquid biopsy results alone

Patient with nebulizer
June 1, 2026/Cancer/Innovations

Adding Novel Inhaled Agent May Improve Lung Cancer Outcomes

Direct delivery of viral-based vector KB707 to the lungs may boost anti-tumor response and help overcome immune checkpoint inhibitor resistance

Ad